Trial funded by Patient-Centered Outcomes Research Institute aims to compare the benefits and risks for two commonly used doses of aspirin in people with heart disease
Anthem Inc. is committed to playing an active role in identifying best approaches to health and care management. As part of that belief, Anthem’s outcomes research subsidiary, HealthCore Inc., will begin reaching out to select members of Anthem affiliated health plans regarding an opportunity to participate in an innovative research study on heart disease. The study is currently underway to help determine the most effective and safest dose of aspirin to prevent heart attacks and strokes, and Anthem’s affiliated health plans are expected to play a significant role in recruitment. ... |